MediLedger announces start of participation in FDA track and trace pilot program
The MediLedger project, a cross-industry effort to enhance the safety and security of the drug supply chain by utilizing a blockchain-based solution built earlier by the MediLedger Project, today announced the commencement of its participation of a new pilot program sponsored by the US Food and Drug Administration (FDA).
The program under development will assist drug supply chain stakeholders in developing an electronic, interoperable system that will identify and trace certain prescription drugs as they are distributed within the United States.
The project, which is being coordinated by San Francisco blockchain technology company Chronicled, is made up of over 20 companies, including large pharmaceutical manufacturers, virtual manufacturers, contract manufacturers, repackagers, wholesale distributors, third-party logistics companies, and major retail pharmacy chains.
Matt Sample, VP of Manufacturing Operations at AmerisourceBergen, commented, "The MediLedger pilot's strength is that it's a cross industry effort to explore the use of a blockchain network to enable the interoperability required by the Drug Supply Chain Security Act (DSCSA) requirements in 2023. The potential solution is especially viable because it's open to all participants in the Pharma industry. We've been working with Chronicled since 2017 on solving these industry challenges and we believe that there is potential to great improvements to the prescription drug supply chain."
Talvis Love, SVP, CIO Pharmaceutical Segment at Cardinal Health, commented, "Cardinal Health is excited to partner with Chronicled. Blockchain provides an alternative to meet the 2023 interoperability requirements for the DSCSA. Specifically, the FDA pilot has the potential to extend the pharmaceutical blockchain business network to meet the requirements and enhance security of prescription drugs and patient safety."
Pablo Medina, Head of US Product Lifecycle and Protection, and Genentech echoed those comments about patient safety, "Further advancement in patient safety in the supply chain can only be achieved by strong cross-industry collaboration and a robust yet efficient technology solution. As founding members of the MediLedger Project, we believe that blockchain technology truly holds promise to further secure the distribution of pharmaceutical products and it is only through a common vision that we will be able to achieve it."
The project is scheduled for completion in November 2019.
New speakers announced for Procurement & Supply Chain Live
Two leading executives in supply chain transformation have been confirmed for this year's Procurement & Supply Chain Live event.
Procurement & Supply Chain Live is the perfect opportunity to hear from prominent executives at the world’s leading procurement and supply chain businesses. The event will be streamed live from Tobacco Dock, London via the leading networking platform Brella.
The three-day show, running 28-30 September 2021, is an essential deep dive into the industry, with influential speakers sharing insights and strategies from their organisations, group roundtable discussions, and fireside chats.
We take a look at the latest additions to the already amazing lineup of speakers announced so far, and what they will bring to the flagship event.
VP Global Supply Chain at Macmillan Education Ltd
Shaun Plunkett has over 30 years of supply chain leadership experience in FMCG, entertainment and media sectors, supporting multi-billion euro businesses including Universal Music, EMI, Sony Music, Harper Collins and Associated British Foods. He has a track record of successfully delivering transformational change coupled with award winning operating models and developing and coaching global teams. Plunkett says that challenging the status quo is at the heart of what drives him on a daily basis - and encouraging others to continuously push the boundaries.
Read more about Plunkett’s involvement in Macmillan Education’s supply chain transformation HERE
Digital Transformation Lead, Oracle UK and Board Member, CILT at Macmillan Education Ltd
Vikram Singla is digital transformation director at Oracle, UK. He helps supply chain and finance business leaders leverage technology to deliver meaningful business outcomes for their organisations. He also serves on the board if CILT (Chartered Institute of Logistics and Transport) – UK and is an Honorary Visiting Fellow at Anglian Ruskin University. Singla has more than 25 years’ experience in the technology sector, and in global supply chain transformation, including deploying business transformation programmes for Fortune 500 firms. In his spare time, Singla is a passionate brand ambassador for Cancer Research.
Plunkett and Singla join a growing line-up of speakers, including: Sheri R. Hinish, IBM; Robert Copeland, G4S; Daniel Weise, BCG; Mark Bromley, Mastercard; David Loseby, Rolls Royce; and Ninian Wilson, Vodafone Procurement Company.